Bdh Industries Ltd vs Shree Ganesh Biotech India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of BDH Industries Ltd is ₹ 403.15 as of 12 Jun 15:30 . The P/E Ratio of BDH Industries Ltd changed from 8.6 on March 2021 to 16.3 on March 2025 . This represents a CAGR of 13.64% over 5 yearsThe P/E Ratio of Shree Ganesh Biotech India Ltd changed from 740.6 on March 2021 to 90 on March 2025 . This represents a CAGR of -34.40% over 5 years The Market Cap of BDH Industries Ltd changed from ₹ 53.19 crore on March 2021 to ₹ 151.46 crore on March 2025 . This represents a CAGR of 23.28% over 5 yearsThe Market Cap of Shree Ganesh Biotech India Ltd changed from ₹ 236.18 crore on March 2021 to ₹ 35.88 crore on March 2025 . This represents a CAGR of -31.40% over 5 years The revenue of BDH Industries Ltd for the Mar '26 is ₹ 29.65 crore as compare to the Dec '25 revenue of ₹ 29.87 crore. This represent the decline of -0.74% The revenue of Shree Ganesh Biotech India Ltd for the Mar '26 is ₹ 2.4 crore as compare to the Dec '25 revenue of ₹ 1.07 crore. This represent the growth of 124.3% The ebitda of BDH Industries Ltd for the Mar '26 is ₹ 4.82 crore as compare to the Dec '25 ebitda of ₹ 4.76 crore. This represent the growth of 1.26% The ebitda of Shree Ganesh Biotech India Ltd for the Mar '26 is ₹ -0.15 crore as compare to the Dec '25 ebitda of ₹ 0.32 crore. This represent the decline of -146% The net profit of BDH Industries Ltd changed from ₹ 1.57 crore to ₹ 2.88 crore over 8 quarters. This represents a CAGR of 35.44% The net profit of Shree Ganesh Biotech India Ltd changed from ₹ 0.24 crore to ₹ -0.15 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of BDH Industries Ltd changed from 28.02 % on March 2021 to 27.96 % on March 2025 . This represents a CAGR of -0.04% over 5 yearsThe Dividend Payout of Shree Ganesh Biotech India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About BDH Industries Ltd

Incorporated in 1990 as a private limited company, BDH Industries Limited (BDHIL) was converted into a public limited company in 1994.
It was established to takeover a going concern, Bombay Drug House Pvt Ltd. This company was amalgamated with BDHIL in 1994 and, since then, it has been manufacturing a wide range of drug formulations in the antibiotic, anti-inflamatory and anti-microbial segments. The Company is engaged in manufacturing of therapeutic formulations covering wide range of Pharmaceuticals and Renewable Energy segments.
BDH offers a full range of Oral Solid Dosages (OSD) technologies.
Research &Development Centre at Kandivali, Mumbai, undertake formulation development projects on new Novel Drug Delivery System (NDDS). It came out with a public issue in Feb.'95, aggregating Rs 6.

About Shree Ganesh Biotech India Ltd

Shree Ganesh Biotech India Limited was incorporated on September 2, 1982, as 'S.P. Commercial Co. Limited' with the Registrar of Companies, West Bengal.
The Company got the Certificate of Commencement of Business on September 14, 1982.
The Company was incorporated with an object to carry on the business of builders, Contractors and to deal in property and also to do investment and finance business. In 2010, pursuant to a Scheme of Amalgamation, Shree Ganesh Bio-Tech (India) Private Limited was merged with S.P. Commercial Co. Limited pursuant to the order of the Hon'ble High at Calcutta dated February 15, 2010.
The entire business of Shree Ganesh Bio-Tech (India) Private Limited consisting of trading and distribution of seeds were transferred to S.P. Commercial Co. Limited.
Subsequently, Shree Ganesh Bio-Tech (India) Private Limited was dissolved pursuant to the said Scheme of Amalgamation and the name of the Company was changed to Shree Ganesh Bio-Tech (India) Limited.

FAQs for the comparison of BDH Industries Ltd and Shree Ganesh Biotech India Ltd

Which company has a larger market capitalization, BDH Industries Ltd or Shree Ganesh Biotech India Ltd?

Market cap of BDH Industries Ltd is 232 Cr while Market cap of Shree Ganesh Biotech India Ltd is 23 Cr

What are the key factors driving the stock performance of BDH Industries Ltd and Shree Ganesh Biotech India Ltd?

The stock performance of BDH Industries Ltd and Shree Ganesh Biotech India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for BDH Industries Ltd and Shree Ganesh Biotech India Ltd?

As of June 15, 2026, the BDH Industries Ltd stock price is INR ₹403.15. On the other hand, Shree Ganesh Biotech India Ltd stock price is INR ₹0.58.

How do dividend payouts of BDH Industries Ltd and Shree Ganesh Biotech India Ltd compare?

To compare the dividend payouts of BDH Industries Ltd and Shree Ganesh Biotech India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.